HODGKIN LYMPHOMA
Clinical trials for HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test exercise as Anti-Aging treatment for cancer survivors
Disease control Not yet recruitingThis study aims to see if exercise and behavioral coaching can slow down accelerated aging in older adults who have survived blood cancers like leukemia and lymphoma. Researchers will enroll 180 participants aged 50+ and randomly assign them to different exercise programs to meas…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test 'One-Two Punch' cell therapy for patients who have run out of options
Disease control Not yet recruitingThis early-stage study is testing a new two-part treatment for adults with aggressive blood cancers that have come back or not responded to other therapies. Doctors will first give patients a transplant of their own genetically edited stem cells, followed by an infusion of their …
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New immune cell therapy targets Tough-to-Treat lymphomas
Disease control Not yet recruitingThis study is testing whether specially modified natural killer (NK) immune cells can help control two types of aggressive lymphoma that haven't responded well to standard treatments. Researchers will give these engineered cells to 100 adults whose lymphoma either didn't respond …
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Could less radiation be enough for hodgkin lymphoma?
Disease control Not yet recruitingThis study aims to see if patients with early-stage Hodgkin lymphoma who respond well to chemotherapy can safely receive a lower dose of radiation therapy. Researchers will compare a reduced radiation dose (20 Gy) to the standard dose (30 Gy) in 518 patients to see if the lower d…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated Mar 16, 2026 15:27 UTC
-
New 'Supercharged' immune cell therapy tested for tough blood cancers
Disease control Not yet recruitingThis early-stage trial is testing a new cell therapy for adults with advanced lymphomas or leukemia that has come back or not responded to other treatments. Doctors will give patients specially modified immune cells (called CAR-NK cells) made from donated cord blood, after a shor…
Matched conditions: HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC
-
Can intense workouts help young cancer survivors rebuild their health?
Symptom relief Not yet recruitingThis pilot study is testing whether a 12-week high-intensity interval training (HIIT) exercise program is practical and safe for young Hodgkin lymphoma survivors who finished treatment within the last two years. Researchers will enroll 20 participants to see if they can complete …
Matched conditions: HODGKIN LYMPHOMA
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC